• Access To Financings
  • Transparent
  • Innovative
  • Well-Connected

Emblem Cannabis’ Advantage Over Peers – Interview With John Stewart, President Emblem Pharmaceutical

Jan 26, 2017

john_stewart_emblemJohn Stewart, President of Emblem Pharmaceutical, used to run the pharmaceutical company behind the narcotic painkiller OxyContin, Purdue Pharma. Since leaving one of the largest privately owned pharmaceutical companies in the world, John is now one of the founders and key people behind Emblem Cannabis Corp.

Emblem IPO’d in December of 2016 and is listed on the Toronto Venture Exchange (TSX-V: EMC) as well as in the U.S. (EMMBF). The Emblem stock instantly became a market darling and is one of the top Canadian Licenced Producers with the largest number of shareholders.

At the Canaccord Cannabis Investment Conference in Vancouver we had the opportunity to talk with John about Emblem and its pharma division. This 20-min piece is a must listen as John is one of the most respected people in the Canadian marijuana industry.

mp3-icon

emblem_banner